PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2018 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Pfizer (PFE) CEO: Currently Focused on Smaller Deals - Bloomberg
January 29, 2019 10:23 AM ESTPfizer (NYSE: PFE) CEO: Currently Focused on Smaller Deals - Bloomberg
Pfizer (PFE) Tops Q4 EPS by 1c, FY EPS Guidance Misses Consensus
January 29, 2019 6:46 AM ESTPfizer (NYSE: PFE) reported Q4 EPS of $0.64, $0.01 better than the analyst estimate of $0.63. Revenue for the quarter came in at $13.98 billion versus the consensus estimate of $13.91 billion.
GUIDANCE:
Pfizer sees FY2019 EPS of $2.82-$2.92, versus the consensus of $3.04. Pfizer sees... More
